Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.
Protease inhibitors, including those used for hep C, and various other drugs may cause drug-drug interactions with statins.
Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.
Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.